All news (page 94)

27 February 2026

aicep Global Parques Enhances Angola Business Park Cooperation

From February 23-26, a visit to Angola focused on sharing best practices, fostering synergies, and exploring collaboration in industry, logistics, and sustainable development.
27 February 2026

Lilly's Olumiant Gains CHMP Nod for Adolescent Alopecia Areata in EU

CHMP backs Olumiant for severe alopecia areata in adolescents, based on Phase 3 study showing 42% achieved 80% scalp hair coverage at 36 weeks. Awaiting European Commission decision.
27 February 2026

KazMunayGas 2025 Trading Update

Hydrocarbon reserves stable; oil and gas production up. Oil transport steady; refining and polypropylene output increased.
27 February 2026

CABB Group Sells Jayhawk Fine Chemicals to Anupam Rasayan

CABB shifts focus to Pharma and Life Science, selling Jayhawk for $150M. Anupam Rasayan aims to expand its US presence and performance materials business.
27 February 2026

Air Liquide and Holcim Partner to Decarbonize Belgian Cement Production

The agreement aims to capture 1.1 million tons of CO₂ annually at Holcim's Obourg plant, supporting EU's 2050 net zero target through advanced carbon capture and storage technology.
27 February 2026

Ercros Reports EUR 8M EBITDA, EUR 54M Loss

Weak demand, high energy costs, and competition impact results. Cost reduction plan on track. Financial debt reduced. Takeover bid rejected. Demand recovery expected in late 2026.
27 February 2026

Neste Board Nominee Withdraws from 2026 AGM Election

Simo Sääskilahti withdraws from Board election. The Board will have eight members. Remaining candidates are proposed for election.
27 February 2026

BASF Advances "Winning Ways" Strategy Milestones

BASF boosts free cash flow, starts Zhanjiang plants, and cuts costs. 2025 EBITDA drops to €6.6B; 2026 outlook: €6.2-7.0B EBITDA, €1.5-2.3B free cash flow.
26 February 2026

GSK's Bepirovirsen Under Review in Japan for Chronic Hepatitis B Treatment

Japan reviews bepirovirsen for chronic hepatitis B. Phase III trials show higher functional cure rates and acceptable safety. SENKU designation granted for expedited review.
26 February 2026

GSK's Linerixibat Gets Priority Review in China for PBC-Related Itch

Linerixibat shows significant improvement in cholestatic pruritus in PBC patients, based on GLISTEN phase III trial data. Regulatory reviews ongoing in US, EU, UK, and Canada.
26 February 2026

thyssenkrupp Automotive Body Solutions Joins IPAI for Smart Manufacturing Innovation

The company joins IPAI to integrate AI in manufacturing, enhancing robotics and expanding globally, with a focus on intelligent production and quality monitoring.
26 February 2026

Indaver to Acquire Medway Energy Centre from Low Carbon

Indaver plans to expand waste treatment in SE England, generating low-carbon electricity. The project aligns with their UK strategy and complements Low Carbon's development efforts.
26 February 2026

Grupa Azoty Introduces New Sulphur-Containing Fertilizer

The new product strengthens the fertilizer segment, supporting stable growth and competition in Europe while enhancing food security in Poland and the region.
26 February 2026

MOL Accuses JANAF of Legal Violations Over Russian Oil Transit

MOL demands JANAF allow unsanctioned Russian oil via sea, citing EU/US rules. Non-compliance may lead to legal action and claims for damages.
26 February 2026

PureCycle Technologies Q4 2025 Results and Update

Record production, revenue growth, expansion in Thailand and Belgium, and leadership changes. Gen-2 design shows cost efficiency. Financials stable with ongoing projects and debt management.
26 February 2026

TotalEnergies to Export 2 Mtpa LNG from Alaska Project for 20 Years

The Alaska LNG project, with a 20 Mtpa capacity, aims to supply Asia, enhancing energy security and transpacific ties. It has strong U.S. support and offers logistical advantages.
26 February 2026

Asahi Kasei Acquires Aicuris for €780 Million

The acquisition enhances Asahi Kasei's pharmaceutical platform in severe infectious diseases, leveraging existing infrastructure for growth and expanding its treatment portfolio.
26 February 2026

FDA Approves Boehringer Ingelheim's HERNEXEOS for HER2-Mutant NSCLC

HERNEXEOS gains FDA approval for HER2-mutant NSCLC, showing a 76% response rate in trials. Further confirmation required for continued approval.
26 February 2026

Uniper's CCO Carsten Poppinga to Depart

Poppinga to join EnBW as Head of Trading post-cooling period. CEO Michael Lewis to cover CCO duties until a successor is named.
26 February 2026

Technip Energies Nominates John O’Higgins and Luc Rémont for Board Positions

Joseph Rinaldi to retire in 2026. John O’Higgins and Luc Rémont nominated as Board Observers, pending shareholder approval for Non-Executive Director roles.
26 February 2026

Johnson & Johnson Reports Positive Early Results for Pasritamig and Docetaxel in Prostate Cancer

Phase 1b study shows pasritamig and docetaxel combo is safe and effective in prostate cancer, with high PSA response rates, supporting Phase 3 trials.
26 February 2026

BASF Introduces Biomass Balance Autofroth Foam for North American Market

BMB Autofroth foam cuts carbon emissions by 18-20%, offers a drop-in solution for sustainability without process changes, and suits various applications.
26 February 2026

BASF Appoints Thomas Biegi for Communications and Government Relations

Thomas Biegi, with a strong background in pharma and biotech communications, will succeed Nina Schwab-Hautzinger in April 2026, reporting to Markus Kamieth.
26 February 2026

Lilly's Orforglipron Outperforms Semaglutide in Diabetes Trial

Orforglipron 36 mg reduced A1C by 2.2% and weight by 9.2%, surpassing semaglutide in a 52-week trial with 1,698 participants. Results published in The Lancet.
26 February 2026

Aramco Advances Gas Expansion with Jafurah and Tanajib Projects

Jafurah and Tanajib projects boost gas production, aiming for 80% capacity increase by 2030, supporting economic growth and energy diversification.
26 February 2026

Boehringer Ingelheim Licenses Immune Disease Program from Sitryx

Boehringer gains exclusive rights to Sitryx's preclinical program for autoimmune diseases, with potential payments over $500M and tiered royalties on future sales.
26 February 2026

Veolia Expands in India with Major Mumbai Water Projects

Secures 15-year contracts for Mumbai's largest water plants, enhancing water security and efficiency with advanced tech, aiming to double India's revenues by 2030.
26 February 2026

Veolia 2025 Results Overview

Strong 2025 results with growth in international markets, early ROCE target achievement, key acquisitions, increased dividend, and positive 2026 outlook.
26 February 2026

Veolia Secures £1bn UK Waste Management Contracts for 2025

11 new contracts with UK local authorities boost Veolia's municipal services by 35%, supporting decarbonisation and resource preservation.
26 February 2026

Eni Reports Strong 2025 Financial and Strategic Progress

Strong Q4 results with 35% net income growth. Major projects launched, production up 7%. LNG expansion, biofuels growth, and strategic partnerships enhance resilience and shareholder returns.

← Previous Next →